v3.20.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
REVENUES        
Total revenues $ 837,714 $ 1,201,127 $ 1,741,781 $ 2,711,962
EXPENSES        
Cost of product sales 318,460 408,203 673,887 724,716
Cost of product sales-related party 603,015 603,890 1,055,510 1,265,157
General and administrative 2,664,658 202,679 4,644,272 471,696
Research and development 870,876 200,217 1,468,221 347,858
Research and development-related party 1,193 540,618
Sales and marketing 98,045 74,518 186,889 176,912
Total expenses 4,555,054 1,490,700 8,028,779 3,526,957
LOSS FROM OPERATIONS (3,717,340) (289,573) (6,286,998) (814,995)
OTHER EXPENSE (INCOME), NET        
Change in fair value of warrant liabilities 4,395,300 20,596,700
Interest expense, net 715 65,480 58,079 135,465
Other income, net (2,447) (248) (252,561) (1,240)
Total other expense (income), net 4,393,568 65,232 20,402,218 134,225
LOSS BEFORE PROVISION FOR INCOME TAXES (8,110,908) (354,805) (26,689,216) (949,220)
PROVISION FOR INCOME TAXES 2,305 1,420 2,902 1,570
NET LOSS $ (8,113,213) $ (356,225) $ (26,692,118) $ (950,790)
Net loss per common share, basic and diluted $ (0.41) $ (0.06) $ (1.87) $ (0.17)
Weighted-average number of shares outstanding, basic and diluted 19,799,468 5,602,214 14,303,058 5,602,214
Net Product Sales [Member]        
REVENUES        
Total revenues $ 361,218 $ 526,865 $ 845,641 $ 1,087,516
Net Product Sales-Related Party [Member]        
REVENUES        
Total revenues 476,496 634,262 896,140 1,584,446
Collaborative Research Revenue [Member]        
REVENUES        
Total revenues $ 40,000 $ 40,000

Source